Skip to content

A randomized study of a 3D-HD or a 2D-4K laparoscopic surgery for gastric cancer.

A randomized study of a 3D-HD or a 2D-4K laparoscopic surgery for gastric cancer. - Laparoscopic surgery for gastric cancer (3D-HD vs 2D-4K)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029227
Enrollment
50
Registered
2017-11-01
Start date
2017-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

3D-HD laparoscopy (1 year) 2D-4K laparoscopy (1 year)

Sponsors

Division of Gastroenterology, Department of Surgery, Graduate School of Medicine, Kobe University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Pathologically diagnosed as gastric cancer 2) T1-T4aN0 or T1-T1aN(+) according to Japanese Classification of Gastric Carcinoma the 14th edition. (N(+) as N1 according to Japanese Classification of Gastric Carcinoma the 13th edition.) 3) Indication of curative resection by distal gastrectomy or total gastrectomy 4) No invading the esophagus or duodenum. 5) 20 years-old or above, 79 years-old or below 6) Performance status (ECOG) 0 or 1 7) BMI(Body mass index) <30 8) The most recent blood examination satisfies following items: (1) WBC: 3,000/mm3 or above (2) PLT: 100,000/mm3 or above (3) T-BIL: 2.0 mg/dL or below (4) AST(GOT): 100 IU/L or below (5) ALT(GPT): 100 IU/L or below (6) CRE: 1.5 mg/dL or below 9) Getting informed consent from the patient in writing

Exclusion criteria

Exclusion criteria: 1) Infectious disease required systemic therapy 2) Body temperature: 38 degrees or above 3) Pregnant, possibility in pregnancy, Within postpartum 28 days or lactating 4) Difficult to cooperate in the trial for psychiatric reasons 5) Administration of steroids or immunosuppressants 6) History of unstable angina pectoris or within six month after acute myocardial infarction 7) Uncontrolled hypertension 8) Uncontrolled diabetes regardless of administration of insulin 9) Respiratory disease receiving continuous oxygen inhalation 10) Surgery for remnant gastric cancer, esophagogastric junction cancer or another simultaneous disease (without cholecystectomy)

Design outcomes

Primary

MeasureTime frame
The operative time (Overall operative time, Partly operative time for each technical part)

Secondary

MeasureTime frame
A number of dissected lymph nodes, Blood loss, A number of bleeding, The rate of infectious complication (pancreatic fistula, abdominal abscess), The postoperative days

Countries

Japan

Contacts

Public ContactHitoshi Harada

Graduate School of Medicine, Kobe University Division of Gastroenterology, Department of Surgery

htharada@med.kobe-u.ac.jp078-382-5925

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026